Enbiosis collaborates with a broad range of healthcare professionals, including MDs, GPs, Functional and Integrative Medicine doctors, naturopaths, dietitians, nutritionists, pharmacists, health coaches, and more.
Microbiome analysis can provide valuable insights for a variety of health conditions. Here’s a list of conditions that can benefit from microbiome analysis:
- Gastrointestinal Disorders: Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), Crohn’s Disease and Ulcerative Colitis
- Metabolic Conditions: Obesity, Type 2 Diabetes, Metabolic Syndrome
- Autoimmune Diseases: Rheumatoid Arthritis, Hashimoto’s Thyroiditis
- Mental Health Disorders: Anxiety, Depression, Autism Spectrum Disorders (ASD)
- Skin Diseases: Eczema (Atopic Dermatitis), Acne, Psoriasis
- Cardiovascular Health: Hypertension, Atherosclerosis
- Hormonal Imbalances: Polycystic Ovary Syndrome (PCOS), Menopause-related symptoms
- Chronic Fatigue Syndrome (CFS), dysbiosis-related issues affecting overall health.
Following the receipt of the stool sample by the lab, it takes around 4 weeks for the results to be ready.
Yes, there is clinical proof and validation studies regarding patients using Enbiosis. We have three publications demonstrating that our AI-powered microbiome analysis, when compared to current nutrition strategies, yielded better outcomes within six weeks. For more detailed information, please visit our publications page.
We provide educational and marketing materials for practitioners following their registration.
Currently, Enbiosis AI-powered microbiome analysis is not covered by insurance.